Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.
about
Smallpox vaccines for biodefense: need and feasibilityGenome-wide association study of antibody response to smallpox vaccineRisks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968Cytokine production associated with smallpox vaccine responsesProspective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic reviewDemographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteersAnticipating demand for emergency health services due to medication-related adverse events after rapid mass prophylaxis campaigns.Emergency response vaccines: lessons learned in response to communicable diseases.The immunology of smallpox vaccines.Gender effects on humoral immune responses to smallpox vaccine.Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Adversomics: the emerging field of vaccine adverse event immunogeneticsPeptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.Unresolved issues in theories of autoimmune disease using myocarditis as a frameworkEffect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypoxReasons physicians accepted or declined smallpox vaccine, February through April, 2003.Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study populationVaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored VaccinesDevelopment of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in miceSequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.Adversomics: a new paradigm for vaccine safety and design.Antibody responses to vaccinia membrane proteins after smallpox vaccination.Application of pharmacogenomics to vaccines.Smallpox vaccines for biodefense.Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.Could autoimmunity be induced by vaccination?Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.Management of myopericarditis.Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.Replicating poxviruses for human cancer therapy.Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.).Defending against smallpox: a focus on vaccines.An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.
P2860
Q22305942-C18B70A8-2A42-4108-9D9C-04BDEB0FF04CQ24612100-447F48D3-6A68-4EE4-BF23-67A2418E7236Q24799168-6ECCA827-9E5D-4E0D-897F-0B1AE5FC05C8Q26823501-0C790389-E51B-4E50-84B3-A04C53293E4EQ28485174-A60BF84A-E1DE-4BC8-92CE-06C26BE2C8CDQ30228332-B1C06DD1-AC92-49E1-B941-B9B1CC6260A6Q30230184-EE2751FC-3F55-449C-A776-6F13F0BF498AQ30336126-4B0A15B2-6D99-42CF-8259-7C9E40776AD5Q33679943-691B4660-B3F0-402A-98BA-B18912CE48A9Q33701473-14E65E39-0C23-4F58-8D4E-E2A440EE549FQ33743444-286D355F-BEED-4C7D-8C3B-849F82C89509Q33744268-F034588C-A28D-4D54-A060-EA7BEB5DE587Q33755146-A2E1F81D-3B56-434E-BC1F-091F3FF382C3Q34452486-708CC406-CEDD-4F5C-9F19-5B999F9CD2B9Q34502997-659612CB-24B4-4899-A5BE-B12749F3B39AQ34648311-1A612AF3-589E-4351-9A9D-071C41F7D815Q34740233-8F118529-8465-436A-A5B9-AAD02CB8D166Q34779016-2ACFBBD6-BCCD-404D-A16D-8E97F26E189FQ34907430-934C5C6E-48B1-4748-A05C-18A432FB3BCEQ34991389-6F59E183-D4DF-4A51-8702-3843CE524266Q35076706-2135DCBC-0ADA-412C-9CCD-6F3D2C14F5E2Q35089019-A502C944-F4D8-43D9-8E12-2233AC2780E8Q35447516-B284A915-7B7A-4D1F-A8BB-07A00856AFB8Q35571248-C16C8482-0249-40FC-9BC9-61DB7EB34753Q35928588-466DC6C7-F593-4F6C-82D0-1DBF0C4ED46BQ35947780-41B6F54E-7C26-47E4-A647-10E0A9889C3CQ36119504-603BF689-C5DF-41E5-8726-D9A5620708B2Q36242667-105605CA-5974-4808-BE26-A2D3A933DF6BQ36869365-0633BDE5-9980-4612-8275-E3914B13D68DQ37293663-4BB96334-8DC2-4603-BBC5-57139EFF0269Q37393765-9F334D48-660D-4937-8791-7DE6D9C1A234Q37456000-BA14AF75-84E8-4F81-A15C-6C6CA54B764EQ37762550-30210560-F790-49B3-B956-860030C5842CQ37791160-9FE591F6-B438-4555-8CC2-378DD8D45CABQ38081155-67530B87-7496-483D-A073-E9D48293A64FQ38222113-DE80BB5B-8270-445F-B8D1-9B50A09ED9D4Q38407351-5FEF4825-A7E2-4570-8610-CE2F8206A0B1Q38615201-5D394D2D-742A-43B7-B61C-B009B31A02A3Q38799357-95E60E03-7645-49EF-A41E-408902864B84Q39764626-C9A8BD4F-1CD0-479D-8C5C-B65AE7D4C515
P2860
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Myopericarditis following smal ...... a-naive US military personnel.
@ast
Myopericarditis following smal ...... a-naive US military personnel.
@en
type
label
Myopericarditis following smal ...... a-naive US military personnel.
@ast
Myopericarditis following smal ...... a-naive US military personnel.
@en
prefLabel
Myopericarditis following smal ...... a-naive US military personnel.
@ast
Myopericarditis following smal ...... a-naive US military personnel.
@en
P2093
P356
P1476
Myopericarditis following smal ...... a-naive US military personnel.
@en
P2093
David N Tornberg
Department of Defense Smallpox Vaccination Clinical Evaluation Team
Duane R Hospenthal
J Edwin Atwood
James R Riddle
Jeffrey S Halsell
John D Grabenstein
Mark K Arness
Pierce Gardner
Robert E Eckart
P304
P356
10.1001/JAMA.289.24.3283
P407
P577
2003-06-01T00:00:00Z